Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Chargement...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Trigonella foenum-graecum var. persica
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
Persian fenugreek lowers blood sugar through multiple mechanisms. The compound 4-hydroxyisoleucine stimulates insulin secretion from pancreatic beta cells, while diosgenin improves insulin sensitivity in peripheral tissues. Galactomannan fiber slows carbohydrate absorption in the gut, reducing post-meal glucose spikes. Additionally, trigonelline may support pancreatic beta cell function. These combined effects make Persian fenugreek valuable for blood sugar management (Evidence Level B). The variety is specifically prized in Unani medicine for these hypoglycemic properties.
No, Persian fenugreek should not be combined with warfarin or other anticoagulant medications. Fenugreek may potentiate the effects of blood thinners, increasing the risk of bleeding complications. This interaction occurs because fenugreek can affect clotting factors and may alter warfarin metabolism. If you take warfarin, clopidogrel, aspirin, or similar anticoagulants, consult your healthcare provider before using any fenugreek supplements. This interaction is clinically significant and well-documented in medical literature.
The typical adult dosage for Persian fenugreek is 5-30 grams of seeds daily, or approximately 600mg of standardized extract. For blood sugar management, doses toward the higher end (15-30g seeds) are commonly used in traditional Unani practice. Seeds can be consumed whole, ground into powder, or brewed as tea. Standardized extracts offer more consistent dosing of active compounds like 4-hydroxyisoleucine. Start with lower doses to assess tolerance and take with food to minimize digestive upset.
Persian fenugreek is unsafe during pregnancy and should be strictly avoided. The herb contains uterine stimulant compounds that can trigger contractions and potentially cause miscarriage or preterm labor. This contraindication applies to both the Persian variety and common fenugreek. While fenugreek is traditionally used as a galactagogue to increase milk supply in breastfeeding mothers, pregnant women should not consume it in medicinal amounts. Small culinary amounts in food may be acceptable, but therapeutic doses pose significant risks.
The most distinctive side effect of Persian fenugreek is a maple syrup-like body odor, caused by sotolone compounds excreted through skin and sweat. This is harmless but often noticeable. Other common side effects include gastrointestinal discomfort, bloating, gas, and diarrhea, particularly when starting supplementation. Hypoglycemia (low blood sugar) can occur, especially in people taking diabetes medications concurrently. Allergic reactions are rare but possible, particularly in those with legume allergies. Side effects are generally mild and often improve with continued use.
Cette plante ne dispose pas d'une monographie rédigée par un humain, et le contenu généré par IA n'est pas affiché ici. Consultez les sources gouvernementales et les études primaires PubMed (NIH) listées ci-dessous pour des informations fiables. Confirmez toujours auprès d'un professionnel de santé avant utilisation.
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.